有效负载多样化克服了抵抗,并指导了乳腺癌的序列抗体-药物结合疗法
Dileep Reddy Rampa1, Minji Seo2, Nanae Ogata1
1University of Hawaii Cancer Center honolulu, Hawaii United States.
概括
转移性乳腺癌 (MBC) 的耐药性通常是由于有效载荷机制,而不是目标损失. 切换到具有不同有效载荷的抗体-药物联合体 (ADC),如微管抑制剂,可以克服耐药性并改善治疗策略.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 癌症治疗方法 癌症治疗方法
背景情况:
- 抗体与药物联合体 (ADC) 已经彻底改变了乳腺癌的治疗方法.
- 像T-DXd和SG这样的批准的ADC提供临床益处,但在转移性环境中面临获得的耐药性.
- 在最初的ADC治疗中进展后,没有明确的策略来测序ADCs.
研究的目的:
- 阐明乳腺癌中对ADCs获得的耐药性机制.
- 在转移性环境中评估ADC的合理测序策略.
- 确定克服ADC耐药性的治疗方法.
主要方法:
- 生成的抗T-DXd (TDXd-R) 和抗SG (SG-R) 的乳腺癌细胞系.
- 评估了抗原表达,内化和抵抗通路,包括流出输送器.
- 在体外和体内测试了非拓酶1 (Topo1) 有效载荷的ADC的有效性.
主要成果:
- 阻力主要是由有效载荷特定的因素介导的,例如流量输送器上调,而不是抗原损失.
- 切换到具有不同有效载荷的ADC (例如微管抑制剂) 恢复了抗瘤活性.
- 交叉阻力与共享有效载荷机制有关,而不是目标表达.
结论:
- 序列ADC的有效性受到共享有效载荷机制的限制,特别是基于Topo1的药物.
- 切换到具有非交叉耐药有效载荷的ADC是克服转移性乳腺癌耐药性的可行策略.
- 有效载荷多样化是ADC测序的临床可行的策略.
相关概念视频
Cancer Therapies
10.1K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.1K
Drug Therapy
269
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
269
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Targeted Cancer Therapies
8.9K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.9K
Conjugated Proteins
28.6K
Simple proteins and protein complexes contain only amino acids. In contrast, many other proteins, called conjugated proteins, covalently bond with non-protein moieties.
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
28.6K
Drug Administration and Therapy Phases: Overview
1.4K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.4K


